Hyderabad: Granules India Limited has announced that the Company's Unit V facility located at Anakapally, Visakhapatnam, ...

The expansion is a natural progression for Upperton who already develops and manufactures small molecule and biological, ...

UK contract development and manufacturing organization Upperton Pharma Solutions has completed the build of its new sterile ...

Upperton Pharma Solutions has taken a £7m leap forward with the launch of its new sterile manufacturing facility in Nottingham.

Hyderabad: CuraTeQ Biologics s.r.o., a step-down subsidiary of Aurobindo Pharma Limited, has announced that the Committee for ...

PHAXIAM Therapeutics (Euronext: PHXM - FR0011471135), a biopharmaceutical company ("PHAXIAM" or "the Company") developing innovative treatments for severe and resistant bacterial infections, announced ...

VectorBuilder's partner, Ucello, announced that its CD19-targeting umbilical cord blood-derived allogeneic CAR-T cell therapy, UC101, received Investigational New Drug (IND) approval from the U.S.

Monster Vape Labs, the originators and producers of Jam Monster e-liquids and disposable vape devices, is proud to announce ...

InstantGMP, a leader in fully integrated GMP-compliant software solutions for pharmaceutical manufacturing, has partnered ...

InstantGMP™, a leader in fully integrated GMP-compliant software solutions for pharmaceutical manufacturing, proudly announces its new partnership with Corsair Pharma, an innovative biopharmaceutical ...

Quarterly season is nearing its end, triggering a rush from small caps to hit the month-end reporting deadline.

Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in treatment space.